In the interest of full disclosure, ASH has asked each of the participating consultants in the Consult a Colleague program to identify any relationships that could influence - or could be perceived as influencing - the content of his or her responses. These disclosures are listed below.

Hemostasis/Thrombosis

Kenneth Bauer, MD
Dr. Bauer indicated he had nothing to disclose.

Joel S. Bennett, MD
Dr. Bennett indicated he had nothing to disclose.

James N. George, MD
Consultant and Research Funding - Amgen, Inc.

Robert R. Handin, MD
Dr. Handin indicated he had nothing to disclose.

Craig Kessler, MD
Consultant - Bayer, Baxter-Immuno, Inc., Amgen, Eisai, Inc., Sanofi-Aventis, Canyon Pharmaceuticals, Ipsen, Inc., Novo Nordisk, Inc.
Research Funding - Grifols, Inc., Novo Nordisk, Inc., Baxter-Immuno, Inc., Wyeth, Inc., Octapharma, Bayer, Sanofi-Aventis, Eisai, Inc., Amgen, Glaxo-Smith-Kline, Canyon, Inc.
Honoraria - Octapharma, Bayer, Baxter-Immuno, Inc., Amgen, Eisai, Inc., Grifols
Paid Testimony - Baxter-Immuno, Inc.
Advisory Boards - Wyeth, Inc., Bayer, Novo Nordisk, Inc., Baxter-Immuno, Inc., Catalyst, Inc., Octapharma, Inc., Sanofi-Aventis, CSL, Inc.

Barbara A. Konkle, MD
Consultancy - Baxter Corporation, Bayer Corporation, Novo Nordisk
Membership Advisory Committee - CSL Behring

Michael H. Kroll, MD
Speakers Bureau - Eisai, Inc.

W. Keith Hoots, MD
Dr. Hoots indicated he had nothing to disclose.

Janna Journeycake, MD
Dr. Journeycake indicated she had nothing to disclose.

Ellis Neufeld, MD, PhD
Research Funding - Bayer, Ferrokin, Inc., Grifols, Novartis, Novo Nordisk
Membership Advisory Board - Grifols

Margaret Ragni, MD, MPH
Dr. Ragni indicated she had nothing to disclose.

Lymphoproliferative Disorders

James O. Armitage, MD
Dr. Armitage indicated he had nothing to disclose.

Aronold S. Freedman, MD
Dr. Freedman indicated he had nothing to disclose.

Stephanie Gregory, MD
Research Funding/Grants - Astellas, Celgene, Cephalon, Genentech, GlaxoSmithKline, Immunomedics, NCIC CTG, Novartis, Onyx
Consultant - Amgen, Genentech (Roche), Novartis, Spectrum Pharmaceuticals
Speakers Bureau - Genentech (Roche), GlaxoSmithKline

Susan O'Brien, MD
Research Support/P.I. - Genentech, Berlex, Biogen Idec, Eli Lilly, Novartis, Bristol-Myers Squibb, GeminX, Genta, Hana Biosciences
Consultant - Genta, Sanofi-Aventis, Celgene
Scientific Advisory Board - GeminX, Biogen Idec, Eli Lilly

Kanti R. Rai, MD
Honoraria - Cephalon, Genentech
Membership Advisory Committee - Cephalon, Genentech, GlaxoSmithKline

Thomas C. Shea, MD
Consultancy - Novartis, Biogen Idec, Genentech, Genzyme

Kenneth McClain, MD, PhD
Stock Ownership - Johnson & Johnson Company
Expert Testimony - Cases regarding hemophagocytic lymphohistiocytosis
Board of Directors - Histiocytosis Association of America

Acute Leukemias

Daniel DeAngelo, MD
Dr. DeAngelo indicated he had nothing to disclose.

Richard Larson, MD
Research Funding - Ambit Bioscience, Amgen, Bristol-Myers Squibb, Celgene, Chroma Therapeutics, Novartis, Sanofi-Aventis
Consultancy - Antisoma, Caremark, Hana Bioscience, Novartis, Trubion
Royalties - UpToDate, Inc.
Honoraria - Bristol-Myers Squibb, Novartis
Equity Ownership - GlaxoSmithKline, Merck

Selina Luger, MD
Dr. Luger indicated she had nothing to disclose.

Steven Gore, MD
Research Funding - Celgene, Johnson & Johnson
Consultancy - Celgene, Eisai
Stock Ownership - Celgene

Stephan Sallan, MD
Research Funding - Enzon, Inc.
Expert Testimony - Legal case, Las Vegas, NV
Scientific Advisory Board - University of Chicago Cancer Center SAB

Wendy Stock, MD
Consultancy - Advisory boards for Berlex, Novartis, Genzyme, Eisai, Sunesis
Have received honoraria for attending advisory board meetings
Research Funding - Berlex through CALGB for correlative science studies

Multiple Myeloma and Waldenström Macroglobulinemia

Paul Richardson, MD
Speakers Bureau and Advisory Boards - Millennium, Celgene, Johnson & Johnson

Sagar Lonial, MD
Consultant - BMS, Celgene, Millenium, Novartis
Research Funding - BMS, Celgene, Millenium, Novartis

Myeloproliferative Disorders

Todd Cooper, DO
Dr. Cooper indicated he had nothing to disclose.

Ross Levine, MD
Consultancy - TargeGen

Ruben Mesa, MD
Dr. Mesa indicated he had nothing to disclose.

Srdan Verstovsek, MD, PhD
Research Funding - AstraZeneca, Celgene, Cephalon, Eli Lilli Company, Exelixis, Incyte, Novartis, Roche, SBIO

Myelodysplastic Syndromes

Maria Baer, MD
Dr. Baer indicated she had nothing to disclose.

Bruce Camitta, MD
Dr. Camitta indicated he had nothing to disclose.

Elihu Estey, MD
Dr. Estey indicated he had nothing to disclose.

H. Jean Khoury, MD
Dr. Khoury indicated he had nothing to disclose.

Gail Roboz, MD
Honoraria - Celgene, Cephalon, ChemGenex, Eisai, EpiCept, Genzyme, Novartis

Mikkael Sekeres, MD, MS
Dr. Sekeres indicated he had nothing to disclose.

David Steensma, MD
Consultancy - Amgen, Novartis

back to top